No CrossRef data available.
Article contents
Conflict of interest declaration
Published online by Cambridge University Press: 08 February 2008
Extract
David Ames has undertaken research with cholinesterase inhibitor drugs supported by Eisai, Janssen, Parke-Davis and Pfizer. He has received honoraria for talks and consultancies and some financial support to enable conference attendance from those four companies and from Novartis, the other pharmaceutical company to market a cholinesterase inhibitor in Australia.
- Type
- For Debate
- Information
- Copyright
- Copyright © International Psychogeriatric Association 2007